In vitro interactions between antiretroviral protease inhibitors and artemisinin endoperoxides against Plasmodium falciparum

被引：14

作者：

He, Zhengxiang ^{[1
]}

Chen, Lili ^{[1
]}

You, Jianlan ^{[1
]}

Qin, Li ^{[1
]}

Chen, Xiaoping ^{[1
]}

机构：

[1] Chinese Acad Sci, Lab Pathogen Biol, GIBH, Ctr Infect & Immun, Guangzhou 510663, Guangdong, Peoples R China

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2010年 / 35卷 / 02期

关键词：

Antiretroviral protease inhibitors; Artemisinin endoperoxides; Antimalarial; Drug interaction; ANTIMALARIAL; CHLOROQUINE; MALARIA; AGENTS; VIVO; COINFECTION; DISCOVERY; ACRIDONES; HIV;

D O I：

10.1016/j.ijantimicag.2009.09.016

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Antiretroviral protease inhibitors (APIs), which are effective at controlling the effects of human immunodeficiency virus (HIV) in patients, have also proven efficacious in inhibiting Plasmodium falciparum growth in vitro. Use of artemisinin-based combination therapies is being encouraged to reduce malaria mortality in areas of P. falciparum resistance to conventional antimalarial drugs. The aim of this study was to investigate drug interactions between HIV protease inhibitors and artemisinin drugs against malaria. In vitro cultures of P. falciparum provide a screen system for identifying and evaluating drug combinations. The derived isobolograms provide clear evidence of antagonistic interactions between artemisinin endoperoxides and several different APIs. (C) 2009 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

引用

收藏

页码：191 / 193

页数：3

相关论文

共 15 条

[1] Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria [J].

Andrews, KT ;

Fairlie, DP ;

Madala, PK ;

Ray, J ;

Wyatt, DM ;

Hilton, PM ;

Melville, LA ;

Beattie, L ;

Gardiner, DL ;

Reid, RC ;

Stoermer, MJ ;

Skinner-Adams, T ;

Berry, C ;

McCarthy, JS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) :639-648

[2] INVITRO AND INVIVO POTENTIATION OF CHLOROQUINE AGAINST MALARIA PARASITES BY AN ENANTIOMER OF AMLODIPINE [J].

DELORON, P ;

BASCO, LK ;

DUBOIS, B ;

GAUDIN, C ;

CLAVIER, F ;

LEBRAS, J ;

VERDIER, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) :1338-1342

[3] Antimalarial drug discovery: Efficacy models for compound screening [J].

Fidock, DA ;

Rosenthal, PJ ;

Croft, SL ;

Brun, R ;

Nwaka, S .

NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (06) :509-520

[4] Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum [J].

Fivelman, QL ;

Adagu, IS ;

Warhurst, DC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) :4097-4102

[5] FLUOXETINE HYDROCHLORIDE ENHANCES INVITRO SUSCEPTIBILITY TO CHLOROQUINE IN RESISTANT PLASMODIUM-FALCIPARUM [J].

GERENA, L ;

BASS, GT ;

KYLE, DE ;

ODUOLA, AMJ ;

MILHOUS, WK ;

MARTIN, RK .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2761-2765

[6] Synergy of human immunodeficiency virus protease inhibitors with chloroquine against Plasmodium falciparum in vitro and Plasmodium chabaudi in vivo [J].

He, Zhengxiang ;

Qin, Li ;

Chen, Lili ;

Peng, Nanzheng ;

You, Jianlan ;

Chen, Xiaoping .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (07) :2653-2656

[7] Chloroquine resistance reversal agents as promising antimalarial drugs [J].

Henry, Maud ;

Alibert, Sandrine ;

Orlandi-Pradines, Eve ;

Bogreau, Herve ;

Fusai, Thierry ;

Rogier, Christophe ;

Barbe, Jacques ;

Pradines, Bruno .

CURRENT DRUG TARGETS, 2006, 7 (08) :935-948

[8] Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum [J].

Kelly, Jane X. ;

Smilkstein, Martin J. ;

Cooper, Roland A. ;

Lane, Kristin D. ;

Johnson, Robert A. ;

Janowsky, Aaron ;

Dodean, Rozalia A. ;

Hinrichs, David J. ;

Winter, Rolf ;

Riscoe, Michael .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (11) :4133-4140

[9] Discovery of dual function acridones as a new antimalarial chemotype [J].

Kelly, Jane X. ;

Smilkstein, Martin J. ;

Brun, Reto ;

Wittlin, Sergio ;

Cooper, Roland A. ;

Lane, Kristin D. ;

Janowsky, Aaron ;

Johnson, Robert A. ;

Dodean, Rozalia A. ;

Winter, Rolf ;

Hinrichs, David J. ;

Riscoe, Michael K. .

NATURE, 2009, 459 (7244) :270-273

[10] Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors [J].

Parikh, S ;

Gut, J ;

Istvan, E ;

Goldberg, DE ;

Havlir, DV ;

Rosenthal, PJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) :2983-2985